A life-span study indicated that plutonium activity in the thoracic ly
mph nodes is a contributor to development of lymphopenia in beagles ex
posed to (PuO2)-Pu-239. Significant lymphopenia was found in 67 (58%)
beagles given a single nose-only exposure to (PuO2)-Pu-239 to result i
n mean initial lung depositions ranging from 0.69 to 213.3 kBq. Lympho
id atrophy and sclerosis of the thoracic lymph nodes and lymphopenia w
ere observed in exposure-level groups with initial lung depositions gr
eater than or equal to 2.5 kBq. Those dogs with final plutonium concen
trations in the thoracic lymph nodes greater than or equal to 0.4 kBq/
g and dose rates greater than or equal to 0.01 Gy/day developed lympho
penia. Marked differences existed between chronically lymphopenic dogs
and intermittently lymphopenic dogs with regard to initial lung depos
ition, time to lymphopenic events and absolute lymphocyte concentratio
ns. Linear regression analysis revealed moderate correlation between r
eduction in lymphocyte values and initial lung deposition, in both mag
nitude and time of appearance after exposure. Cumulative dose and dose
rate appeared to act together to produce initial effects on lymphocyt
e populations, while dose rate alone appeared to be responsible for th
e maintenance and subsequent cycles of lymphopenia seen over the life
span. No primary tumors were associated with the thoracic lymph nodes
in this study, although 70% of the lymphopenic dogs developed lung tum
ors. (C) 1995 by Radiation Research Society